Incisive Genetics: Raises $2.5M in Seed Funding

Incisive Genetics Raises $2.5M in Seed Funding

  • Incisive Genetics, a Vancouver BC-based held biotech company, raised $2.5M in seed funding
  • The round was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC
  • The company intends to use the funds to develop its manufacturing process and capabilities, advance key studies to enhance its gene editing delivery platform technology
  • Established in 2018 and led by Dr. Blair R. Leavitt, IncisiveGenetics provides a non-viral delivery platform for genetic therapies
  • This delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles
  • The company’s pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns.Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration.Highlights: ECB partners with key global standard setters.Agreements aim...

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly.Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...